Advertisement

Topics

ratiopharm GmbH Company Profile

12:25 EDT 30th May 2016 | BioPortfolio

ratiopharm is one of the leading international generics producer and in our home country Germany the top selling and most commonly prescribed pharmaceutical brand. We produce high quality medicines and sell them at low prices. By doing so, we contribute to cost containment in the healthcare sector.
With about 750 medicines, available exclusively from pharmacies, ratiopharm has one of the widest product ranges in the business. We sell 353 million pack units every year, meeting the needs of virtually all areas of medicine, from allergies to circulation problems and from gastroenteritis to toothaches.

Location

Graf-Arco-Straße 3
Ulm
89079
Germany

Contact

Phone: 49 731 402 02
Fax: 49 731 402 78 32
Email: info@ratiopharm.de


News Articles [151 Associated News Articles listed on BioPortfolio]

Teva Buy Ratiopharm, PTV News: Mar 19, 2010

Israeli generics giant Teva buys ratiopharm to become biggest in Europe

Ratiopharm-Mutter Teva mit Gewinneinbruch - Top-Arznei schwächelt

JERUSALEM (dpa-AFX) - Der Ratiopharm-Mutterkonzern Teva hat sich 2015 mit einem teuren Rechtsstreit und einer geplatzten Übernahme einen herben Gewinnrückgang eingebrockt. Unter dem Strich verdien.....

Ratiopharm-Mutter Teva macht mehr Gewinn

JERUSALEM (dpa-AFX) - Der Ratiopharm-Mutterkonzern Teva hat im ersten Quartal trotz eines Umsatzrückgangs mehr Gewinn erwirtschaftet. Unter dem Strich verdiente der israelische Pharmahersteller in...

Ratiopharm-Mutter Teva investiert kräftig in Standort Ulm

ULM (dpa-AFX) - Die Ratiopharm-Mutter Teva will kräftig in den Standort Ulm investieren. Ein höherer dreistelliger Millionenbetrag soll in den Ausbau der Biotech-Anlage fließen, teilte der Konzern....

Ratiopharm-Mutter leidet unter Konkurrenz für Kassenschlager: Negative Wechselkurseffekte und starke ...

Negative Wechselkurseffekte und starke Konkurrenz nagen am Umsatz des israelischen Generika-Herstellers Teva. Dennoch übertrifft die Ratiopharm-Mutter ihre Jahresziele - und geht auf Einkaufstour.S.....

EU-Kommission gibt grünes Licht für Milliarden-Deal: Brüssel stimmt dem Milliarden-Deal zu: Die Ratiopharm-Mutter ...

Brüssel stimmt dem Milliarden-Deal zu: Die Ratiopharm-Mutter Teva darf den irischen Generika-Hersteller Allergan übernehmen. Doch die Erlaubnis gilt nur unter bestimmten Auflagen.Die EU-Kommission ....

Thermosome raises €4.6m

Thermosome GmbH, an emerging biopharmaceutical company, announced the closing of its first financing round, raising net proceeds of approximately €1.9 million from funds managed by High-Tech Gründe...

Original-Research: 4SC AG (von EQUITS GmbH): -

Original-Research: 4SC AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu 4SC AG Unternehmen: 4SC AG ISIN: DE000A14KL72 Anlass der Studie: Peergroup Analyse, Initial Empfehlung: - Kursziel: - Kurs...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Risperidone [Ratiopharm Inc]

These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE.RISPERIDONE tabletsInitial U.S. Approval 1993

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Brachytherapy.

To examine a novel technique for simplified placement and removal of plaque brachytherapy by fibrin glue and urokinase (medac Gmbh, Hamburg, Germany).

Preliminary Experience with a New Multidirectional Videoendoscope for Neuroendoscopic Surgical Procedures.

We assessed the applicability of a new multidirectional videoendoscope (digiCAMeleon, Karl Storz GmbH, Tuttlingen, Germany) in various neuroendoscopic procedures.

The Degree of Anisocoria in Pediatric Patients With Horner Syndrome When Compared to Children Without Disease.

To study the magnitude of anisocoria in pediatric patients using the plusoptiX A08 (plusoptiX GmbH, Nuremberg, Germany) photoscreener as compared to a literature review of pediatric patients with know...

A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.

U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausan...

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.

This ongoing, prospective, open-label, non-comparative, multicenter phase IV study is evaluating the safety and efficacy of recombinant human growth hormone (rhGH; Omnitrope(®), Sandoz GmbH) in short...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein

Protocol title: Effect of acute alcohol consumption on the activity of major cytochrome P450 enzymes, NAT2 and P-glycoprotein. Objectives: The study is mainly conducted to evaluate the ef...

Telemedicine Monitoring of Sleep Apnea in Stroke

Study Objectives: Meta-analyses report a high prevalence of moderate to severe sleep apnea of more than 50% in stroke patients, with adherence rates for CPAP therapy of only 30%. T...

Companies [4 Associated Companies listed on BioPortfolio]

ratiopharm GmbH

ratiopharm is one of the leading international generics producer and in our home country Germany the top selling and most commonly prescribed pharmaceutical brand. We produce high quality medicines an...

Ratiopharm

On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm Gm...

Merckle GmbH

Die Merckle GmbH zählt zu den führenden Arzneimittelherstellern Europas. Zusammen mit dem Tochterunternehmen ratiopharm GmbH, der meistverwendeten und meistverordneten Arzneimittelmarke in Deutschla...

BioGeneriX AG

As a strategic start-up the BioGeneriX AG aims to develop bioengineered drugs for known targets. The unique character of BioGeneriX was moulded in a particular entrepreneurial setting within the exist...

More Information about "ratiopharm GmbH" on BioPortfolio

We have published hundreds of ratiopharm GmbH news stories on BioPortfolio along with dozens of ratiopharm GmbH Clinical Trials and PubMed Articles about ratiopharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ratiopharm GmbH Companies in our database. You can also find out about relevant ratiopharm GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...


Corporate Database Quicklinks



Searches Linking to this Company Record